Tarek Hassaan Mouhieddine - Abu Haidar Neuroscience Institute, American University of Beirut Medical Center

基本信息

浏览量：20

职业迁徙

个人简介

Tarek Hassaan Mouhieddine is currently a clinical fellow in the Department of Hematology and Oncology at Icahn School of Medicine at Mount Sinai.

研究兴趣

论文共 124 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Determinants of Response to Anti-CD38 and Bispecific Combination Therapy in Patients with Relapsed/Refractory Multiple Myeloma

Adolfo Aleman,Ariel Kogan Zajdman,Tarek Mouhieddine,Bhaskar Upadhyaya,Oliver Van Oekelen,Alessandro Lagana, Leah Grossman,Santiago Thibaud, Larysa Sanchez, Shambavi Richard,Adriana Rossi,Joshua Richter,Hearn Jay Cho,Cesar Rodriguez-Valdes,Ajai Chari, Samir Parekh

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2024): S41-S41

引用0浏览0引用

P-003 Determinants of Response to Anti-CD38 and Bispecific Combination Therapy in Patients with Relapsed/Refractory Multiple Myeloma

Adolfo Aleman,Ariel Kogan Zajdman,Tarek Mouhieddine,Bhaskar Upadhyaya,Oliver Van Oekelen,Alessandro Lagana, Leah Grossman,Santiago Thibaud,Larysa Sanchez, Shambavi Richard,Adriana Rossi,Joshua Richter,Hearn Jay Cho,Cesar Rodriguez-Valdes, Ajai Chari,Samir Parekh

Clinical Lymphoma Myeloma and Leukemia (2024): S41

引用0浏览0引用

P-059 Ferritin Dynamics Are Associated with Clinical Outcomes of Multiple Myeloma Patients Receiving Bispecific Antibodies

Tarek Mouhieddine,Tianxiang Sheng, Bruno Costa, Nathaniel Saffran,Darren Pan,Santiago Thibaud,Larysa Sanchez, Shambavi Richard,Adriana Rossi,Hearn Jay Cho,Joshua Richter,Cesar Rodriguez-Valdes,Ajai Chari,Samir Parekh,Erin Moshier,Sundar Jagannath

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2024): S75-S75

引用0浏览0引用

Multiple Myeloma Risk and Outcomes Are Associated with Pathogenic Germline Variants in DNA Repair Genes

BLOOD CANCER DISCOVERYno. 6 (2024): 428-441

引用0浏览0WOS引用

How to Identify and Manage High-Risk Smoldering Multiple Myeloma

Tarek H. Mouhieddine

Current Oncology Reportspp.1-12, (2024)

引用0浏览0WOS引用

Abstract 3619: Post CAR-T Lymphocytosis As a Surrogate of BCMA CAR-T Expansion, Response, and Prognosis in Multiple Myeloma

Mateo Mejia Saldarriaga,Darren Pan,Caitlin Unkenholz,Tarek Mouhieddine, Josh Fein,Jorge Monge,Cara Rosenbaum,Roger Pearse,David Jayabalan,Christian Gordillo,Hei Ton Chan,Markus Mapara,Giorgio Inghirami,Suzanne Lentzsch, Ren Reshef,Adriana Rossi,Samir Parekh,Sundar Jagannath, Shambavi Richards,Ruben Niesvizky,Mark Bustoros

CANCER RESEARCHno. 6 (2024)

引用0浏览0引用

Addition of Elotuzumab to Backbone Treatment Regimens for Multiple Myeloma: an Updated Meta-Analysis of Randomized Clinical Trials

Bruno Almeida Costa,Thomaz Alexandre Costa,Gabriel Cavalcante Lima Chagas,Tarek H. Mouhieddine,Joshua Richter,Saad Z. Usmani,Sham Mailankody,Sridevi Rajeeve,Hamza Hashmi

Clinical Lymphoma Myeloma and Leukemia（2024）

引用0浏览0WOS引用

P-053 Early Absolute Lymphocyte Count after BCMA CAR-T As a Surrogate for CAR-T Expansion, Response, and Progression Free Survival in Multiple Myeloma

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2024): S71-S72

引用0浏览0引用

P-386 Effect of Prior Selinexor Exposure on Clinical Outcomes of Chimeric Antigen Receptor T-cell (CAR-T) Therapy for Relapsed/Refractory Multiple Myeloma (RRMM): A Real-World Descriptive Analysis

Bruno Costa, Jack Khouri,Tomer Mark, Stephen Ijioma, David Ray,George Dranitsaris, Norah Sadek, Danai Dima,Erin Moshier,Tarek Mouhieddine,Tianxiang Sheng,Adriana Rossi

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2024): S256-S256

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn